8-K
filed June 26, 2023, 7:59 PM ET
ticker PVLA
CIK 0001583648
other material
confidence high
sentiment neutral
materiality 0.40
Stockholders approve 6M share increase under 2020 equity plan and adoption of 2023 ESPP
PALVELLA THERAPEUTICS, INC.
- At June 21 annual meeting, stockholders approved amendment to 2020 equity incentive plan adding 6,000,000 shares.
- Stockholders approved the 2023 Employee Stock Purchase Plan.
- Elected directors Stephen S. Yoder, Michael Richman, and Matthew L. Sherman as Class III directors.
- Ratified Ernst & Young as independent auditor for FY2023; approved say-on-pay compensation on non-binding basis.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
PALVELLA THERAPEUTICS, INC. shareholders approved Ratification of appointment of Ernst & Young LLP as independent auditor at the 2023-06-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
4. Auditor Ratification Votes For Votes Against Votes Abstained Broker Non-Votes 44,353,310 96,301 394,192 -
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
PALVELLA THERAPEUTICS, INC. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2023-06-21 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
5. Say on Pay Votes For Votes Against Votes Abstained Broker Non-Votes 17,227,404 2,828,509 5,556,466 19,231,424
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
PALVELLA THERAPEUTICS, INC. shareholders approved Approval of amendment to the 2020 EIP at the 2023-06-21 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
2. 2020 EIP Amendment Approval Votes For Votes Against Votes Abstained Broker Non-Votes 18,811,753 6,306,669 493,957 19,231,424
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
PALVELLA THERAPEUTICS, INC. shareholders approved Approval of 2023 ESPP at the 2023-06-21 meeting.
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
3. 2023 ESPP Approval Votes For Votes Against Votes Abstained Broker Non-Votes 19,672,797 410,705 5,528,877 19,231,424
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
PALVELLA THERAPEUTICS, INC. shareholders approved Election of Directors at the 2023-06-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
1. Election of Directors Name Votes For Votes Withheld Broker Non-Votes Stephen S. Yoder 25,191,766 420,613 19,231,424 Michael Richman 23,534,942 2,077,437 19,231,424 Matthew L. Sherman, M.D. 25,191,653 420,726 19,231,424
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.